B Braun Sterilog Limited
B. Braun Sterilog Limited, a prominent player in the medical technology sector, is headquartered in Great Britain and operates extensively across Europe and beyond. Founded in 1839, the company has established itself as a leader in the development and manufacturing of innovative medical devices and solutions, particularly in the fields of infusion therapy, pain management, and surgical instruments. Renowned for its commitment to quality and safety, B. Braun Sterilog offers a diverse range of products, including sterile medical supplies and advanced infusion systems, which are designed to enhance patient care and streamline clinical workflows. The company’s dedication to research and development has positioned it as a trusted partner in healthcare, achieving notable milestones in product innovation and market expansion. With a strong focus on sustainability and customer satisfaction, B. Braun Sterilog continues to set industry standards while contributing to improved health outcomes globally.
DitchCarbon Score
How does B Braun Sterilog Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
B Braun Sterilog Limited's score of 28 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
B Braun Sterilog Limited's reported carbon emissions
In 2023, B Braun Sterilog Limited reported total carbon emissions of approximately 568,000,000 kg CO2e for both Scope 1 and Scope 2 emissions. This marks a reduction from 2022, where emissions were about 612,300,000 kg CO2e, and from 2021, which saw emissions of approximately 653,400,000 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. B Braun Sterilog Limited's emissions data indicates a focus on direct and indirect emissions, as evidenced by their reporting of Scope 1 and Scope 2 emissions. However, there is currently no available data on Scope 3 emissions. The company’s ongoing efforts to address climate change are crucial in the context of the healthcare industry, which is increasingly prioritising sustainability and carbon reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 653,400,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 653,400,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
B Braun Sterilog Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
